Literature DB >> 10385769

Insights into the contemporary epidemiology and outpatient management of congestive heart failure.

F A McAlister1, K K Teo, M Taher, T J Montague, D Humen, L Cheung, M Kiaii, R Yim, P W Armstrong.   

Abstract

OBJECTIVES: To evaluate the epidemiology, prognosis, and patterns of practice in patients with chronic congestive heart failure (CHF) treated and followed at a specialized clinic.
METHODS: Prospective cohort study of consecutive patients referred to and followed up in a specialized heart failure clinic between September 1989 and March 1996.
RESULTS: Of the 628 patients referred, 566 were confirmed to have CHF. Mean duration of follow-up was 518 +/- 490 days (range 1 to 2192 days). Vital status was available for 99.3% of patients. Mean age at enrollment was 66 years, 68% were men, 67% had an ischemic cause of heart disease, and 78% had systolic dysfunction. Patients with preserved systolic function were older, more often female, had higher mean systolic blood pressures, and a lower prevalence of ischemic heart disease, ventricular arrhythmias, or impaired renal function when compared with those with systolic dysfunction (all P </=.001). Although there was a significant negative trend in survival with decreasing ejection fraction (P =. 03), the survival experience of those with CHF and preserved systolic function did not significantly differ from those with systolic failure (P =.25). Multiple logistic regression analysis showed increased mortality risk was associated with increasing age, New York Heart Association class IV, ischemic cause of disease, elevated serum creatinine level, use of diuretics, and systolic dysfunction, whereas use of beta-blockers was associated with reduced risk.
CONCLUSIONS: Our data suggest that a specialized outpatient clinic can improve practice patterns in patients with CHF. The high mortality risk in CHF with preserved systolic function suggests the need to find efficacious (and effective) therapies for this condition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385769     DOI: 10.1016/s0002-8703(99)70251-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  20 in total

Review 1.  Cost-effectiveness of cardiac resynchronization therapy plus an implantable cardioverter-defibrillator in patients with heart failure: a systematic review.

Authors:  Abedin Teimourizad; Aziz Rezapour; Saeed Sadeghian; Masih Tajdini
Journal:  Cost Eff Resour Alloc       Date:  2021-05-21

2.  Recombinant human GHRH(1-44)NH2: clinical utility and therapeutic development program.

Authors:  M R Ehlers
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

3.  Referral and use of heart failure clinics: what factors are related to use?

Authors:  Shannon Gravely; Liane Ginsburg; Donna E Stewart; Susanna Mak; Sherry L Grace
Journal:  Can J Cardiol       Date:  2012-02-25       Impact factor: 5.223

4.  Impact of specialist follow-up in outpatients with congestive heart failure.

Authors:  Justin A Ezekowitz; Carl van Walraven; Finlay A McAlister; Paul W Armstrong; Padma Kaul
Journal:  CMAJ       Date:  2005-01-18       Impact factor: 8.262

5.  Clinical implications of an accurate problem list on heart failure treatment.

Authors:  Daniel M Hartung; Jacquelyn Hunt; Joseph Siemienczuk; Heather Miller; Daniel R Touchette
Journal:  J Gen Intern Med       Date:  2005-02       Impact factor: 5.128

Review 6.  Underutilisation of ACE inhibitors in patients with congestive heart failure.

Authors:  T J Bungard; F A McAlister; J A Johnson; R T Tsuyuki
Journal:  Drugs       Date:  2001       Impact factor: 9.546

7.  Association of diastolic dysfunction and outcomes in ambulatory older adults with chronic heart failure.

Authors:  Ali Ahmed
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-10       Impact factor: 6.053

8.  Evolving approaches to the management of heart failure with preserved ejection fraction in patients with coronary artery disease.

Authors:  Sanjiv J Shah
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-01

9.  Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial.

Authors:  Kamlesh Khunti; Margaret Stone; Sanjoy Paul; Jan Baines; Louise Gisborne; Azhar Farooqi; Xiujie Luan; Iain Squire
Journal:  Heart       Date:  2007-02-19       Impact factor: 5.994

Review 10.  Cardiac resynchronization: a brief synopsis part I: patient selection and results from clinical trials.

Authors:  David M Kalinchak; Mark H Schoenfeld
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.